All In Biotech

Drugs by condition

Drugs approved for restless legs syndrome

Brand-name prescription drugs and biologics whose FDA label lists restless legs syndrome as an approved use. Matched on the label phrases: "restless legs".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

2

Still marketed, NDA or BLA

Drug classes

2

Novel drugs

2

New molecular entities and new biologics

In development

0

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for restless legs syndrome.

  • Horizant (Gabapentin Enacarbil) · Azurity NovelOrphanApr 6, 2011
  • Neupro (Rotigotine) · Ucb INC NovelMay 9, 2007

All approved drugs for restless legs syndrome, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 14 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Nonergot Dopamine Agonist (1)

  • Neupro Rotigotine · Ucb INC · 2007

Class not listed in FDA's data (1)

  • Horizant Gabapentin Enacarbil · Azurity · 2011

Drugs in development for restless legs syndrome

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline

No investigational drugs in Phase 2 or 3 trials list this condition.

More on restless legs syndrome: recruiting trials · published research

Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Huntington's disease chorea

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.